Mantle Cell Lymphoma

Featured

Quiz
Quiz: Is Pre-Transplant MRD Status Predictive of Survival in MCL?
True of False: MRD status prior to autologous stem cell transplantation is an early predictor of PFS and OS in younger patients with MCL.
News
Real-World Practice Patterns, Comorbidities in Medicare Patients With MCL
Older patients with MCL have a high rate of comorbidities impacting treatment choices and OS.
News
MRD Linked to Worse Survival Outcomes in Patients With MCL
Positive MRD status after induction and consolidation treatments for patients with MCL is associated with worse PFS and…
Conference Coverage
Pre-Transplant MRD Status Predicts PFS, OS in Patients With MCL
MRD status in peripheral blood or bone marrow prior to autoSCT is an early predictor of PFS and OS in younger patients…
Special Reports
Product Perspectives: Brukinsa (Zanubrutinib) for Mantle Cell Lymphoma (Sponsored)
An interview with David Andorsky, MD, Rocky Mountain Cancer Centers, Boulder, Colorado.

News

Real-World Practice Patterns, Comorbidities in Medicare Patients With MCL
MRD Linked to Worse Survival Outcomes in Patients With MCL
Treatment Patterns and Outcomes Among US Patients With MCL Treated With Ibrutinib
Significant Economic and Health-Related QoL Burden Associated With MCL

Podcast

Novel BTK Inhibitor Promising for Mantle Cell Lymphoma

Conference Coverage

Clinical and Economic Burden of MCL in the VHA Population
Back to Top